LEADER 02205oam 2200625 450 001 9910709661503321 005 20180531110808.0 035 $a(CKB)5470000002471620 035 $a(OCoLC)896811001 035 $a(OCoLC)995470000002471620 035 $a(EXLCZ)995470000002471620 100 $a20141123d1985 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aGeology and geochronology of granitoid and metamorphic rocks of late Archean age in northwestern Wisconsin /$fby P.K. Sims [and three others] 210 1$aWashington :$cDepartment of the Interior, U.S. Geological Survey,$d1985. 215 $a1 online resource (iii, C17 pages) $cillustrations, maps 225 1 $aGeological Survey professional paper ;$v1292-C 225 1 $aContributions to the geology of the Lake Superior Region 300 $aTitle from title screen (viewed October 14, 2014). 300 $a"A description of Archean rocks in the Puritan batholith." 320 $aIncludes bibliographical references (pages C15, C17). 606 $aGranite$zWisconsin 606 $aMetamorphic rocks 606 $aGeological time 606 $aGeology, Stratigraphic$yArchaean 606 $aArchaean Geologic Period$2fast 606 $aGeological time$2fast 606 $aGeology, Stratigraphic$2fast 606 $aGranite$2fast 606 $aMetamorphic rocks$2fast 607 $aWisconsin$2fast 615 0$aGranite 615 0$aMetamorphic rocks. 615 0$aGeological time. 615 0$aGeology, Stratigraphic 615 7$aArchaean Geologic Period. 615 7$aGeological time. 615 7$aGeology, Stratigraphic. 615 7$aGranite. 615 7$aMetamorphic rocks. 700 $aSims$b P. K$g(Paul Kibler),$f1918-2011,$076550 712 02$aGeological Survey (U.S.), 801 0$bCOP 801 1$bCOP 801 2$bOCLCO 801 2$bOCLCF 801 2$bGPO 906 $aBOOK 912 $a9910709661503321 996 $aGeology and geochronology of granitoid and metamorphic rocks of late Archean age in northwestern Wisconsin$93465957 997 $aUNINA LEADER 05315nam 2200637 450 001 9910787804503321 005 20230807204504.0 010 $a1-61705-141-1 035 $a(CKB)2670000000573352 035 $a(EBL)1827582 035 $a(SSID)ssj0001367456 035 $a(PQKBManifestationID)12613004 035 $a(PQKBTitleCode)TC0001367456 035 $a(PQKBWorkID)11444356 035 $a(PQKB)11564616 035 $a(MiAaPQ)EBC1827582 035 $a(Au-PeEL)EBL1827582 035 $a(CaPaEBR)ebr10962306 035 $a(CaONFJC)MIL655049 035 $a(OCoLC)894629981 035 $a(EXLCZ)992670000000573352 100 $a20150105h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aASPC manual of preventive cardiology /$feditors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal 210 1$aNew York :$cdemosMEDICAL,$d2015. 210 4$d©2015 215 $a1 online resource (295 p.) 300 $aDescription based upon print version of record. 311 $a1-936287-86-2 311 $a1-322-23769-7 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aCover; Title; Copyright; Contents; Contributors; Foreword; Preface; Acknowledgments; Share ASPC Manual of Preventive Cardiology; Chapter 1: National Burden of Cardiovascular Disease and Associated Risk Factors; Cardiovascular Disease; Mortality and Morbidity Attributable to CVD; Prevalence and Control of Cardiovascular Risk Factors; Subclinical Atherosclerosis; Ankle-Brachial Index; Economic Costs of Cardiovascular Disease; Summary; Acknowledgments; References; Chapter 2: Cardiovascular Risk Assessment; Rationale for Contemporary CV Risk Prediction 327 $aRelative Risk Versus Absolute Cardiovascular RiskTreatment Benefit Depends on Absolute Risk Rather Than Relative Risk; Multiple, Online Risk Prediction Tools for CVD are Widely Available; Current Guideline Recommendations; Current Clinical Practice Guidelines Suggest That the Indication and Intensity of Treatment Should Be Proportional to the Absolute Risk for CVD; Novel Developments in Global CVD Risk: Considering Alternative CVD Outcomes; Novel Developments in Global CVD Risk: Considering Alternative Risk Factors; Novel Serum Markers; Novel Imaging Markers; Other Risk Markers 327 $aNovel Developments in Global CVD Risk: Considering Long-Term or Lifetime RiskConclusion; References; Chapter 3: The New American Prevention Guidelines: Aligning the Guidelines for Atherosclerotic Cardiovascular Risk Reduction With the Evidence; A New Approach; Major Themes; What You Need to Know; A. Heart Healthy Nutrition and Physical Activity Behaviors; B. Recommendations from the Risk Assessment Workgroup With Those Reflecting Expert Opinion Highlighted in Italics; C. Graded Recommendations for Statin Treatment to Reduce ASCVD Risk 327 $aFootnotes to this Section (from the Cholesterol Guideline Report)Statin Safety Recommendations; Footnotes to this Section (from the Cholesterol Guideline Report); Monitoring Statin Therapy; Optimizing Statin Therapy; Insufficient Response to Statin Therapy; Footnotes to this Section (from the Cholesterol Guideline Report); Conclusions; References; Chapter 4: Management of High Blood Pressure; Epidemiology of Hypertension; Definition and Classification of Hypertension; Initial Evaluation of the Patient; Thresholds for Initiating Therapy; Lifestyle Modifications; Initial Drug Therapy 327 $aGoal Blood Pressure for "Uncomplicated" Hypertensive PatientsGoal Blood Pressure for Hypertensive Patients with Other High-Risk Conditions; Other Issues; References; Chapter 5: Smoking and Passive Smoking; Smoking and Cardiovascular Disease; Secondhand Smoke; Trends in Cigarette Smoking; Prevention and Reduction of Tobacco Use Among Youth; Prevention and Cessation Programs for Adults; Cessation Strategies for Individuals; Behavioral Treatments; Pharmacologic Interventions; Clinical Approaches; Conclusions; References; Chapter 6: Metabolic Syndrome; History, Prevalence, and Epidemiology 327 $aDefinition 330 $aEndorsed by the American Society for Preventive Cardiology, this highly practical resource focuses on the application of current guidelines and practice standards in the clinical management of cardiovascular risk factors. The Manual presents concise descriptions of each major cardiovascular risk factor, and practical, to-the-point discussions of current best practices in clinical management. In addition, the Manual includes chapters on peripheral arterial disease, stroke, smoking, contemporary cardiovascular imaging, heart failure, metabolic syndrome, thrombosis, nutrition, special populations 606 $aCardiovascular system$xDiseases$xPrevention 615 0$aCardiovascular system$xDiseases$xPrevention. 676 $a616.1/05 702 $aWong$b Nathan D. 702 $aAmsterdam$b Ezra A. 702 $aBlumenthal$b Roger S. 712 02$aAmerican Society for Preventive Cardiology, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910787804503321 996 $aASPC manual of preventive cardiology$92486349 997 $aUNINA LEADER 01662nam0 22003491i 450 001 UON00492164 005 20231205105336.845 010 $a28-520-3826-9 100 $a20190205d1998 |0itac50 ba 101 $afre 102 $aFR 105 $a|||| ||||| 200 1 $aMiscellanea mediaevalia$emélanges offerts à Philippe Ménard$fétudes réunies par J. Claude Faucon, Alain Labbé et Danielle Quéruel 210 $aParis$cChampion$d1998 215 $a2 v. (1534 p. compl.)$d23 cm. 316 $aDono Prof. Alberto Varvaro.$5IT-UONSI F. Varvaro02961 316 $aDono Prof. Alberto Varvaro.$5IT-UONSI F. Varvaro02962 410 1$1001UON00288204$12001 $aNouvelle Bibliothèque du Moyen Age$1210 $aParis$cH. Champion$v46 606 $aLetteratura francese$xSec. 13.-16.$xSaggi$3UONC094588$2FI 620 $aFR$dParis$3UONL002984 676 $a809.02$cStoria delle letterature antiche - Sec. 6.-15.$v21 702 1$aMénard$bPhilippe$3UONV122345 702 1$aFaucon$bJ. Claude$3UONV240802 702 1$aLabbé$bAlain$3UONV240803 702 1$aQuéruel$bDanielle$3UONV098010 712 $aChampion$3UONV248947$4650 801 $aIT$bSOL$c20250613$gRICA 912 $aUON00492164 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI F. Varvaro0296 1 $eSI 27548 7 Dono Prof. Alberto Varvaro. 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI F. Varvaro0296 2 $eSI 27548/a 7 Dono Prof. Alberto Varvaro. 996 $aMiscellanea mediaevalia$9216665 997 $aUNIOR